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The present investigation is aimed to utilize the desolvation process for the preparation of stable egg albumin 
nanoparticles (EA-NP). The minimum size of 125nm with 0.072 polydispersity index (PI) has been obtained at  
pH 9.0, temperature 450C when ethanol addition rate was 1ml/min at agitation speed of 650 rpm. Optimized desolvation 
condition has been utilized for the encapsulation of gallic acid (an anticancer agent) by taking 1:1, 2:1, 4:1 and 8:1 egg 
albumin/gallic acid ratio. The drug loading capacity of about 28% (w/w) and entrapment efficiency (EE) of 91% (w/w) was 
obtained at 2:1 polymer/drug ratio. 
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Introduction 
Gallic acid is a well known anticancer compound 
and can be delivered to brain by a suitable carrier
1
. 
Colloidal nano carriers play a vital role in the area of 
drug delivery by improving the bioavailability and 
therapeutic index of the administrated drug. The 
particle size and surface charge is crucial for retention 
of colloidal drug delivery system and distribution of 
drug in human body. In recent decades several 
investigations are focused on production of albumin 
nanoparticles for targeted delivery
2-5
. Protein and 
functionalized protein nanoparticles have been 
effectively employed for heavy metal removal
6
 and 
for biomedical imaging
7
. Numerous reports are 
available on synthesis and process optimization of 
bovine and human serum albumin nanoparticles using 
desolvation process
8-10
.The present work is aimed at 
the process optimization for the preparation of EA 
nanoparticles by desolvation process using EDC as 
crosslinker. A nanoencapsulation process of 
desolvation under optimized condition was used to 
prepare GA-EA-NP in various ratio of EA/GA. The 
prepared GA-EA-NPmay possibly serve as candidate 
for brain-targeted drug delivery system.  
 
Materials and methods 
Egg albumin powder and N-(3-dimethylaminopropyl)-
N-ethylcarbodiimide hydrochloride (EDC. HCl) were 
purchased from Himedia. Gallic acid was 
commercially supplied by Acros organics. Ethanol 
and all other chemicals were procured from Sigma 
Aldrich. All the chemicals used were of analytical 
grade and used without further purification. EA-NP 
and GA-EA-NP were prepared by a simple 
disolvation process at 45°C temperature. In principle 
to 4 ml aqueous solution of egg albumin under stir 
ing at 750 rpm, desolvating agent ethanol was  
added drop wise with a constant flow rate (1ml/min) 
until the solution becomes just turbid. To induce 
particle crosslinking, EDC was added under stirring 
for 6 hours and left overnight at 45°C temperature. 
The prepared nanoparticles(93% yeild) were  
purified with 3 cycles of centrifugation at 18000 rpm 
at 4°C for 15 min before lyophilization. The average 
size of prepared nanoparticles, polydispersity  
index (PI) and zetapotential were measured at 25°C 
using a Malvern zetasizer (Nano ZS series, Malvern 
Instruments Ltd., Malvern, UK) with a scattering 
angle of 173
0
. In order to synthesize GA entrapped 
EA nanoparticles, GA was added to EA solution at 
pH 9.0 by taking 1:1, 2:1, 4:1 and 8:1 egg 
albumin/gallic acid ratio and the experiments were 
performed as above. The drug loading capacity and 
entrapment efficiency of successfully prepared  
GA-EA-NP was calculated by determining the  
non-entrapped GA present in supernatant phase 
through UV-Visible spectrophotometer. For this 
purpose a standard calibration curve was plotted 
——————— 
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between GA concentrations and absorbance. The data 
represented is the average of three run. 
 
Result and Discussion 
Only a slight influence on particle size was 
observed in the EA concentration range of 5mg/ml to 
50mg/ml with a minimum particle diameter of around 
125nm (PI ~ 0.072) at 10mg/ml EA concentration. 
There was also no appreciable change on the surface 
charge of the resulting nanoparticles on increasing the 
egg white concentration. High protein concentration 
may result in coagulation due to hydrophobic and 
electrostatic interactions subsequently resulting in 
larger particle size. The influence of desolvating agent 
on particle size was checked by varying the ethanol 
addition rate from 0.5 – 4.0 ml/min. Addition rate of 
1.0 to 2.0 ml/min led to formation of more uniform 
size (125 nm) EA nanoparticles with PI of about 
0.072. The particles diameter increases with further 
increase in ethanol addition rate. In the current 
investigation rate of ethanol addition was fixed at 
1ml/min for the production of nanoparticles that also 
supports the report of Ko et al.
8
.The size of protein 
particles is highly influenced by the pH. Larger 
protein particles are expected near the isoelectric 
point (pI) which may be due to the enhanced 
hydrophobic interaction among protein particles 
leading to coagulation. The isoelectric point (pI) of 
EA is 4.6 – 4.8. The size and stability of EA 
nanoparticles were evaluated over a pH range of  
2-12 (Figure1). Under acidic condition (pH 2-3) due 
to enhanced positive surface charge, electrostatic 
interaction increases while hydrophobic interaction 
decreases which allowed smaller particle formation 
since the possibility of coagulation of protein 
molecules is reduced. Strong hydrophobic interaction 
with almost neutral surface charge resulted in larger 
particle size near the isoelectric point of egg albumin. 
Hydrogen bonding decreases the hydrophobicity of 
protein molecules in basic medium. In higher pH 
medium nanoparticles exhibit negative surface 
charge. Strong electrostatic repulsion and reduced 
hydrophobicity among the protein molecules allowed 
them to stay apart which results in smaller particle 
diameter. To obtain EA particles in nano range, 
different stirring rates ranging from 250 to 850 rpm 
with drop wise addition of ethanol to aqueous solution 
of albumin was investigated. Agitation speed from 
550 to 850 rpm resulted in smaller size while stirring 
rate below 350 rpm produced particles of relatively 
larger size, being maximum of 450 nm at 250 rpm. 
The aggregation of particles at low stirring may be the 
reason of large particle diameter
10
.Nanoparticles 
obtained after desolvation process using ethanol were 
unstable and had a possibility of redesolving. To 
stabilize the formed nanoparticles EDC was added as 
a cross-linker. 5 mg of crosslinker was sufficientto 
prepare EA nanoparticles in around 125nm range, 
excess of EDC leads to larger particle size or even 
precipitation. The optimized desolvation condition 
(Egg Albumin: 10 mg/ml, Ethanol Rate: 1ml/min., 
Stirring Rate: 650 rpm, EDC: 5mgand Temperature: 
45
0
C) has been utilized to prepare GA-EA-NP in 
different EA/GA ratio at pH 9.0. It was observed that 
the particle diameter decreases with increasing 
concentration of EA. The maximum loading capacity 
of 28% with PI 0.132 was observed when EA/GA 
ratio is 2:1 (Table 1).Afterwards the GA loading 
percentage was remarkably decreased due the 
increased amount of nanoparticles formation. On the 
other hand the GA entrapment efficiency was 
increased constantly to about 90%, this may be due to 
the increased desolvated EA involved in entrapping 
 
 
Fig. 1 — Effect of egg white concentration on particle size and 
zeta potential Preparation condition: 10% Egg white: 4.0 ml, 
Ethanol Rate: 1ml/min., Stirring Rate: 550 rpm, Gluter aldehyde: 
120 µl, Temperature: 25°C 
Table 1 — Particle size, Zeta potential, PI, Encapsulating 
Efficiency and Loading Capacity of GA-EA-NP 
EA : 
GA 
Particle 
Size  
(nm) 
Zeta 
potential 
(mV) 
PI Encapsulating 
Efficiency  
% 
Loading 
Capacity  
% 
1:1 210 -30.4 0.322 34.2 16.8 
2:1 180 -29.9 0.132 91.2 28.1 
4:1 164 -29.5 0.189 89.6 15.6 
8:1 158 -30.2 0.213 90.5 13.3 
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the water soluble drug. The typical SEM image of the 
prepared GA-EA-NP appeared spherical in shape as 
shown in Figure2. 
 
Conclusion 
The current study demonstratesa simple 
desolvation method for the preparation of EA-NP and 
GA-EA-NPusing EDC as crosslinker. The effect of 
various process parameters indicates that pH is the 
key parameter which strongly influences the particle 
diameter. The prepared GA-EA-NP shows 91% 
entrapment efficiency and 28% loading capacity at 
2:1 polymer/drug ratio. The negative GA-EA-NP 
ranged 150-210 nm could serve as good candidate for 
brain-targeted drug delivery system.  
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Fig. 2 —SEM Photograph of GA-EA-NP 
 
